Experts on prostate cancer discuss the benefits to multidisciplinary care as it pertains to PSMA-PET imaging.
Published data show value of ClarityDX Prostate for prostate cancer screening
June 27th 2024"Using this as an adjunctive test after PSA screening will give physicians more information to help decide if their patient should undergo a prostate biopsy or not,” says M. Eric Hyndman, MD, PhD, FRCSC.